ACUTE ORAL TOXICITY OF BAUHINIA VARIEGATA AND MADHUCA LONGIFOLIA IN MICE

Authors

  • PRAGATI KHARE Department of Pharmacy, Shri Ram Murti Smarak, C. E. T., Bareilly, U. P., India
  • KAMAL KISHORE Department of Pharmacy, M. J. P. Rohilkhand University, Bareilly, U. P., India
  • DINESH KUMAR SHARMA Department of Pharmacy, Himalayan Institute of Pharmacy and Research, Dehradun, U. K., India

DOI:

https://doi.org/10.22159/ijcpr.2022v14i2.1966

Keywords:

Acute oral toxicity, Leguminosae, Sapotaceae, Bauhinia variegata, Madhuca longifolia

Abstract

Objective: Bauhinia variegata and Madhuca longifolia, which belongs to Leguminosae and Sapotaceae, respectively, is traditionally used in India for the cure of many diseases. This study represents the result of acute oral toxicity of Bauhinia variegata and Madhuca longifolia on swiss albino mice.

Methods: Following acute oral administration of 2500 mg/kg crude extracts of Bauhinia variegata and Madhuca longifolia to swiss albino mice, no mortalities or evidence of adverse effects were observed.

Results: The results of this study agree with those of in vitro experiments, indicating that the use of Bauhinia variegata and Madhuca longifolia leaves is scientifically validated.

Conclusion: The result was in agreement with that of in vitro experiments, whereby the crude extracts of Bauhinia variegata and Madhuca longifolia did not show toxicity. Based on the outcome of acute toxicity in experimental mice, the crude extracts of both Bauhinia variegata and Madhuca longifolia could be regarded as safe in experimental mice. Further toxicity study over a longer period of time involving detection of effects on vital organ functions would ensure that the plants are safe for human consumption.

Downloads

Download data is not yet available.

References

Wills RB, Bone K, Morgan M. Herbal products: active constituents, modes of action and quality control. Nutr Res Rev. 2000;13(1):47. doi: 10.1079/095442200108729007, PMID 19087433.

Patil JK, Patel MR, Sayyed HY, Patel AA, Pokal DM, Suryawanshi HP, Ahirrao RA. Pharmacognostic and phytochemical investigation of Bauhinia variegata (Linn.) Benth. stem bark. Pharm Sci Monit. 2012;3(1).

Deswal G, Arora K. Ethnobotany and phytopharmacology of Bauhinia variegata. Int J Pharm Drug Anal. 2015;11:261-3.

Prashar Y, Kumar AS. Anti-obesity activity of Bauhinia variegata Linn in high-fat diet-induced obesity in female mice. Pharmacologyonline. 2010;2:1008-16.

Yadava RN, Reddy VM. Anti-inflammatory activity of a novel flavonol glycoside from the Bauhinia variegata Linn. Nat Prod Res. 2003;17(3):165-9. doi: 10.1080/1478641031000104127, PMID 12737399.

Dahake AP, Chakma CS, Chakma RC, Bagherwal P. Antihyperglycemic activity of methanolic extract of Madhuca longifolia bark. Diabetol Croat. 2010;39:3-8.

Annalakshmi R, Uma R, Chandran GS, Sahayam CS, Charles A. Evaluation of Physico-chemical constants and phytochemical analysis of Madhuca longifolia. Int J Nat Prod Res. 2012;1:64-6.

Akhil M, Sarma SKD, Poornachandra RGVN, Jyothi Ch. VS, Kumar RD. Evaluation of the anthelminthic activity of leaves of Madhuca longifolia. Int J Pharmacol Toxicol. 2014;4:99-104.

Kumar KP, Vidyasagar G, Ramakrishna D, Reddy IM, Gupta VSSS, Raidu Ch. S. Screening of Madhuca indica for Antidiabetic Activity in streptozotocin and streptozotocin-nicotinamide induced Diabetic Mice. Int J PharmTech Res. 2011;3:1073-7.

Velioglu YS, Mazza G, Gao L, Oomah BD. Antioxidant activity and total phenolics in selected fruits, vegetables, and grain products. J Agric Food Chem. 1998;46(10):4113-7. doi: 10.1021/jf9801973.

Deciga Campos M, Rivero Cruz I, Arriaga Alba M, Castaneda Corral G, Angeles-López GE, Navarrete A, Mata R. Acute toxicity and mutagenic activity of Mexican plants used in traditional medicine. J Ethnopharmacol. 2007;110(2):334-42. doi: 10.1016/j.jep.2006.10.001, PMID 17101253.

Olson H, Betton G, Robinson D, Thomas K, Monro A, Kolaja G, Lilly P, Sanders J, Sipes G, Bracken W, Dorato M, Van Deun K, Smith P, Berger B, Heller A. Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul Toxicol Pharmacol. 2000;32(1):56-67. doi: 10.1006/rtph.2000.1399, PMID 11029269.

Kola I, Landis J. Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov. 2004;3(8):711-5. doi: 10.1038/nrd1470, PMID 15286737.

Ukelis U, Kramer PJ, Olejniczak K, Mueller SO. Replacement of in vivo acute oral toxicity studies by in vitro cytotoxicity methods: opportunities, limits and regulatory status. Regul Toxicol Pharmacol. 2008;51(1):108-18. doi: 10.1016/j.yrtph.2008.02.002, PMID 18362045.

OECD (Organization for economic co-operation and development. Harmonized integrated hazard classification system for human health and environmental effects of chemical substances. Paris: OECD; 1998.

Walum E. Acute oral toxicity. Environ Health Perspect. 1998;106Suppl 2:497-503. doi: 10.1289/ehp.98106497, PMID 9599698.

Oliver JA. Opportunities for using fewer animals in acute toxicity studies. In: Chemicals testing and animal welfare. Sweden: The National Chemicals Inspectorat; 1986. p. 119-42.

Published

15-03-2022

How to Cite

KHARE, P., K. KISHORE, and D. K. SHARMA. “ACUTE ORAL TOXICITY OF BAUHINIA VARIEGATA AND MADHUCA LONGIFOLIA IN MICE”. International Journal of Current Pharmaceutical Research, vol. 14, no. 2, Mar. 2022, pp. 69-71, doi:10.22159/ijcpr.2022v14i2.1966.

Issue

Section

Original Article(s)